Why Now is the Time to Buy U.S. Cannabis Stocks

By |

Watch

Midas Letter

The Digital Businesss Channel for Cannabis, Crypto and Technology Stocks.

Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.

Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.

Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.

If you think 2020 has been volatile in the stock market, you haven’t been invested in cannabis for an extended period of time…

Before 2019, cannabis stocks everywhere gave investors 3 years of gains… But that all changed when the cannabis bubble burst around April 2019…

There are a variety of reasons why cannabis companies colossal valuations were massively deflated…

1.There is no money in solely growing cannabis (anyone can do it…)

2. Canadian black-market still dominates

3. Supply issues and slow physical dispensary rollout

4. Share dilution

5. Fraud…

But, we are seeing a massive resurgence in U.S. multi-state operator stocks… Some stocks (such as GrowGeneration Corp NASDAQ:GRWG) were up around 500% since the COVID lows.

There are a variety of reasons why this is true and why it will continue to be true for certain companies who have the strategic advantage over others.

Watch the full interview to see how legality will affect the cannabis market with elections coming up and what U.S. marijuana stocks are poised to explode higher…

Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.

Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.

Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.